Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-resistant Prostate Cancer M Zou, R Toivanen, A Mitrofanova, N Floc'h, S Hayati, Y Sun, ... Cancer Discovery, CD-16-1174, 2017 | 346 | 2017 |
Direct reprogramming of fibroblasts into neural stem cells by single non-neural progenitor transcription factor Ptf1a D Xiao, X Liu, M Zhang, M Zou, Q Deng, D Sun, X Bian, Y Cai, Y Guo, ... Nature communications 9 (1), 1-19, 2018 | 88 | 2018 |
Forkhead box N4 (Foxn4) activates Dll4-Notch signaling to suppress photoreceptor cell fates of early retinal progenitors H Luo, K Jin, Z Xie, F Qiu, S Li, M Zou, L Cai, K Hozumi, DT Shima, ... Proceedings of the National Academy of Sciences 109 (9), E553-E562, 2012 | 83 | 2012 |
Brn3a/Pou4f1 regulates dorsal root ganglion sensory neuron specification and axonal projection into the spinal cord M Zou, S Li, WH Klein, M Xiang Developmental biology 364 (2), 114-127, 2012 | 77 | 2012 |
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance JM Arriaga, S Panja, M Alshalalfa, J Zhao, M Zou, A Giacobbe, ... Nature Cancer 1 (11), 1082-1096, 2020 | 69 | 2020 |
Tfap2a and 2b act downstream of Ptf1a to promote amacrine cell differentiation during retinogenesis K Jin, H Jiang, D Xiao, M Zou, J Zhu, M Xiang Molecular brain 8 (1), 1-14, 2015 | 69 | 2015 |
Predicting drug response in human prostate cancer from preclinical analysis of in vivo mouse models A Mitrofanova, A Aytes, M Zou, MM Shen, C Abate-Shen, A Califano Cell reports 12 (12), 2060-2071, 2015 | 47 | 2015 |
Somatic tissue engineering in mouse models reveals an actionable role for WNT pathway alterations in prostate cancer metastasis J Leibold, M Ruscetti, Z Cao, YJ Ho, T Baslan, M Zou, W Abida, J Feucht, ... Cancer discovery 10 (7), 1038-1057, 2020 | 46 | 2020 |
Generation of self-organized sensory ganglion organoids and retinal ganglion cells from fibroblasts D Xiao, Q Deng, Y Guo, X Huang, M Zou, J Zhong, P Rao, Z Xu, Y Liu, ... Science Advances 6 (22), eaaz5858, 2020 | 32 | 2020 |
OncoLoop: A network-based precision cancer medicine framework A Vasciaveo, JM Arriaga, FN de Almeida, M Zou, EF Douglass Jr, ... Cancer discovery 13 (2), 386-409, 2023 | 24 | 2023 |
Selective neuronal lineages derived from Dll4‐expressing progenitors/precursors in the retina and spinal cord M Zou, H Luo, M Xiang Developmental Dynamics 244 (1), 86-97, 2015 | 13 | 2015 |
Effect of sodium butyrate and propionate on cell growth, metabolism and expression of the chimeric antibody J Ma, Y Dong, M Zou, L Cheng, J Liu JOURNAL OF CHINESE BIOTECHNOLOGY 25 (10), 16, 2005 | 7 | 2005 |
Reprogramming Fibroblasts to Neural Stem Cells by Overexpression of the Transcription Factor Ptf1a K Jin, M Zou, D Xiao, M Xiang Stem Cell Transcriptional Networks, 245-263, 2020 | 4 | 2020 |
OncoLoop: Closing the loop between patient-centered drug discovery and preclinical testing in precision-oncology A Vasciaveo, M Zou, J Arriaga, A Califano, C Abate-Shen Cancer Research 80 (16 Supplement), 822-822, 2020 | | 2020 |
Identifying drivers for advanced prostate cancer by a transposon-based genetic screen M Zou, A Vasciaveo, A Califano, C Abate-Shen Cancer Research 78 (13 Supplement), 3017-3017, 2018 | | 2018 |
Alterations of TP53 mediate resistance to abiraterone in castration-resistant prostate cancer M Zou, R Toivanen, A Mitrofanova, MM Shen, C Abate-Shen Cancer Research 76 (14 Supplement), 4387-4387, 2016 | | 2016 |